{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:36:45Z","timestamp":1773866205911,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1136\/ijgc-00009577-200207000-00010","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T07:54:45Z","timestamp":1717055685000},"page":"389-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Breast cancer risk assessment in patients seen in a gynecologic oncology clinic"],"prefix":"10.1016","volume":"12","author":[{"given":"B.E.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0005","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white female who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0010","unstructured":"Anderson SJ, Ahnn S, Duff K. NSABP Breast cancer prevention trial risk assessment program, Version 2. NSABP Biostatistical Center Technical Report. August 14, 1992."},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0015","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/jnci\/86.8.620","article-title":"Validation of a breast cancer risk assessment model in women with a positive family history","volume":"86","author":"Bondy","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0025","doi-asserted-by":"crossref","unstructured":"Spiegelman D, Colditz GA, Hunter D et al. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600\u20137.","DOI":"10.1093\/jnci\/86.8.600"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jnci\/86.8.573","article-title":"Epidemiology and biostatistics program of the National Cancer Institute","volume":"86","author":"Gail","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0035","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0040","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/jnci\/91.21.1829","article-title":"Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer","volume":"91","author":"Gail","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0045","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1200\/JCO.1999.17.5.1632","article-title":"National surgical adjuvant breast and bowel project breast cancer prevention trial: a reflective commentary","volume":"17","author":"Fisher","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0050","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/jnci\/87.10.720","article-title":"Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age","volume":"87","author":"Black","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/gyno.2001.6160","article-title":"Breast cancer assessment in indigent women at a public hospital","volume":"81","author":"Abu-Rustum","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0060","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/ Progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0065","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1200\/JCO.1999.17.9.2659","article-title":"Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"17","author":"Day","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0070","first-page":"169","article-title":"Decision analysis of tamoxifen for the prevention of invasive breast cancer","volume":"6","author":"Grann","year":"2000","journal-title":"Cancer J"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0075","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1200\/JCO.1999.17.6.1939","article-title":"American Society of Clinical Oncology Technical Assessment on Breast Cancer Risk Reduction Strategies: tamoxifen and raloxifene","volume":"17","author":"Chlebowski","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnci\/93.5.358","article-title":"Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention","volume":"93","author":"Rockhill","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-00009577-200207000-00010_bb0085","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/jnci\/91.21.1792","article-title":"Risk\/ben- efit assessment of tamoxifen to prevent breast cancer-still a work in progress?","volume":"91","author":"Taylor","year":"1999","journal-title":"J Natl Cancer Inst"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2412021X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2412021X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200207000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:20:27Z","timestamp":1753222827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2412021X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":17,"aliases":["10.1046\/j.1525-1438.2002.01112.x"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S1048891X2412021X"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200207000-00010","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast cancer risk assessment in patients seen in a gynecologic oncology clinic","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200207000-00010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 IGCS","name":"copyright","label":"Copyright"}]}}